News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,801 Results
Type
Article (8016)
Company Profile (140)
Press Release (476644)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166745)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52876)
Employer Resources (14)
FDA (9760)
Job Trends (8574)
News (238191)
Policy (17906)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (105)
Alzheimer's disease (977)
Antibody-drug conjugate (ADC) (264)
Approvals (10382)
Artificial intelligence (323)
ASCO (159)
Autoimmune disease (206)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (511)
Cancer (3661)
Cardiovascular disease (218)
Career advice (245)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (478)
Cervical cancer (34)
Clinical research (47893)
Collaboration (1245)
Commercialization (3)
Compensation (1472)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (754)
Cystic fibrosis (85)
Data (5676)
Denatured (4)
Depression (102)
Dermatology (63)
Diabetes (344)
Diagnostics (4188)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73723)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87650)
Executive appointments (702)
FDA (12407)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (922)
Gene editing (125)
Generative AI (9)
Gene therapy (319)
GLP-1 (290)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9320)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (256)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (10)
Liver cancer (44)
Longevity (17)
Lung cancer (510)
Lymphoma (252)
Machine learning (27)
Management (3)
Manufacturing (536)
Marketing (8)
MASH (118)
Medical device (8659)
Medtech (8805)
Mergers & acquisitions (14386)
Metabolic disorders (709)
mRNA (57)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (40)
Neuroscience (1829)
NextGen: Class of 2026 (3150)
Non-profit (842)
Obesity (225)
Opinion (10)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (198)
Parkinson's disease (201)
Partnered (12)
Patents (477)
Patient recruitment (511)
Peanut (31)
People (41248)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15471)
Phase 2 (21386)
Phase 3 (14413)
Pipeline (7383)
Policy (18)
Postmarket research (1570)
Preclinical (6539)
Press Release (34)
Prostate cancer (190)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (576)
Real estate (3019)
Recruiting (6)
Regulatory (14843)
Reports (21)
Research institute (582)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (325)
Venture capital (17)
Weight loss (73)
Women's health (81)
Date
Today (45)
Last 7 days (224)
Last 30 days (1641)
Last 365 days (19026)
2026 (12441)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34592)
2021 (37167)
2020 (33479)
2019 (23256)
2018 (17493)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21683)
2013 (18135)
2012 (20222)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17903)
Australia (2098)
California (12012)
Canada (3157)
China (527)
Colorado (485)
Connecticut (411)
Delaware (208)
Europe (24630)
Florida (1798)
Georgia (385)
Hawaii (3)
Idaho (46)
Illinois (702)
India (51)
Indiana (314)
Iowa (15)
Japan (406)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1205)
Massachusetts (7871)
Michigan (308)
Minnesota (563)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2627)
New Mexico (12)
New York (2824)
North Carolina (1285)
North Dakota (4)
Northern California (6021)
Ohio (280)
Oklahoma (14)
Oregon (16)
Pennsylvania (2258)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4990)
Tennessee (120)
Texas (1946)
United States (38986)
Utah (361)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (931)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
484,801 Results for "bionovelus inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
BioNovelus, Inc. Announces Additions to its Finance Team
BioNovelus, Inc. (OTC: ONOV) announces two additions to its finance team.
December 17, 2019
·
1 min read
Business
BioNovelus, Inc. Announces Trey Blalock to Join Advisory Board
BioNovelus, Inc. (OTC: ONOV) announces that Trey Blalock joined the Company’s Advisory Board. BioNovelus’ Advisory Board seats individual entrepreneurs and senior Information Warfare, (IW), Cyber Security / Information Technology (IT) executives with business, government and technical expertise useful for assisting in identifying, integrating and growing acquired companies
December 3, 2019
·
3 min read
BioCapital
BioNovelus, Inc. Announces Name Change to Castellum, Inc.
BioNovelus, Inc. (OTC: ONOV) announces that its corporate name change to Castellum, Inc. has been processed by FINRA, has been published on the “Daily List” on January 23, 2020, and will become effective today.
January 24, 2020
·
1 min read
Business
BioNovelus, Inc. Announces Austin Branch to Join Advisory Board
BioNovelus, Inc. (OTC: ONOV) announces that Austin Branch has joined the Company’s Advisory Board. BioNovelus’ Advisory Board seats individual, entrepreneurs, senior information technology (IT), cybersecurity, Information Warfare (IW), Electronic Warfare (EW), and government technology executives with business and technical expertise useful for assisting in identifying, integrating and growing acquired companies.
January 21, 2020
·
1 min read
Business
BioNovelus, Inc. Announces Patricia Frost to Join Advisory Board
BioNovelus, Inc. (OTC: ONOV) announces Patricia Frost has joined the Company’s Advisory Board. BioNovelus’ Advisory Board seats individual entrepreneurs and senior cyber security / information technology (IT) executives with business, government and technical expertise useful for assisting in identifying, integrating and growing acquired companies.
October 22, 2019
·
3 min read
Deals
BioNovelus, Inc. Announces the Closing of its Acquisition of Corvus Consulting, LLC
BioNovelus, Inc. announces the closing of its previously announced acquisition of Corvus Consulting, LLC..
November 27, 2019
·
2 min read
BioCapital
BioNovelus, Inc. Announces Hiring of RSM US LLP as Firm’s Auditor
BioNovelus, Inc. (OTC: ONOV) announces that it has hired RSM US LLP (“RSM”) as the firm’s external, PCAOB-qualified auditor.
January 22, 2020
·
1 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Business
BioNovelus Announces Filing of Third Quarter 2019 Financial Report
BioNovelus, Inc. (OTC: ONOV) announces it has submitted its 2019 3Q report on www.otcmarkets.com.
November 12, 2019
·
1 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
1 of 48,481
Next